285 related articles for article (PubMed ID: 37275244)
1. Advances in transdermal siRNAs delivery: A review of current research progress.
Sufianov A; Beilerli A; Kudriashov V; Ilyasova T; Wenjie B; Beylerli O
Noncoding RNA Res; 2023 Sep; 8(3):392-400. PubMed ID: 37275244
[TBL] [Abstract][Full Text] [Related]
2. [Research progress in transdermal delivery for small interfering RNA].
Chen Y; Xu N; Hu Z
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):622-631. PubMed ID: 32347057
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptides as a novel transdermal drug delivery system.
Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
[TBL] [Abstract][Full Text] [Related]
4. Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles.
Ita K
Biomed Pharmacother; 2017 Mar; 87():311-320. PubMed ID: 28064104
[TBL] [Abstract][Full Text] [Related]
5. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in nonviral vectors for gene delivery.
Guo X; Huang L
Acc Chem Res; 2012 Jul; 45(7):971-9. PubMed ID: 21870813
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.
Jain S; Patel N; Shah MK; Khatri P; Vora N
J Pharm Sci; 2017 Feb; 106(2):423-445. PubMed ID: 27865609
[TBL] [Abstract][Full Text] [Related]
8. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
9. Challenges and Strategies for Topical and Transdermal Delivery of Bioactive Peptides.
Jiménez-Rodríguez A; Guardado-Félix D; Antunes-Ricardo M
Crit Rev Ther Drug Carrier Syst; 2022; 39(1):1-31. PubMed ID: 34936316
[TBL] [Abstract][Full Text] [Related]
10. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
Uchida T; Kanazawa T; Takashima Y; Okada H
Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
[TBL] [Abstract][Full Text] [Related]
11. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
[TBL] [Abstract][Full Text] [Related]
12. A review of nanocarriers for the delivery of small interfering RNA.
Kesharwani P; Gajbhiye V; Jain NK
Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
[TBL] [Abstract][Full Text] [Related]
13. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.
Desai P; Patlolla RR; Singh M
Mol Membr Biol; 2010 Oct; 27(7):247-59. PubMed ID: 21028936
[TBL] [Abstract][Full Text] [Related]
14. Transdermal delivery of therapeutic agents using dendrimers (US20140018435A1): a patent evaluation.
Yang J; Hu J; He B; Cheng Y
Expert Opin Ther Pat; 2015; 25(10):1209-14. PubMed ID: 26150049
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach.
Coutinho MF; Santos JI; S Mendonça L; Matos L; Prata MJ; S Jurado A; Pedroso de Lima MC; Alves S
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785133
[TBL] [Abstract][Full Text] [Related]
16. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery systems of small interfering RNA by systemic administration.
Kawakami S; Hashida M
Drug Metab Pharmacokinet; 2007 Jun; 22(3):142-51. PubMed ID: 17603214
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
Li H; Tsui TY; Ma W
Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
[TBL] [Abstract][Full Text] [Related]
19. Folate Receptor-Mediated siRNA Delivery: Recent Developments and Future Directions for RNAi Therapeutics.
Gangopadhyay S; Nikam RR; Gore KR
Nucleic Acid Ther; 2021 Aug; 31(4):245-270. PubMed ID: 33595381
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous nanocarrier-mediated delivery of siRNAs and chemotherapeutic agents in cancer therapy and diagnosis: Recent advances.
Bidar N; Darroudi M; Ebrahimzadeh A; Safdari M; de la Guardia M; Baradaran B; Goodarzi V; Oroojalian F; Mokhtarzadeh A
Eur J Pharmacol; 2022 Jan; 915():174639. PubMed ID: 34919890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
